[Phenylbutazone and DRESS syndrome].
Service de Dermatologie, Hôpital Fournier, 36, quai de la Bataille, 54000 Nancy, France. jl.schmutz@chu-nancy.fr
J-L
JL
Schmutz
A
A
Barbaud
P
P
Trechot
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D018771:Arthralgia / Q000188:drug therapy; D017963:Azithromycin / Q000009:adverse effects; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis*; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006621:Hip Joint; D006801:Humans; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D017963:Azithromycin; D010653:Phenylbutazone